FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models.
Saved in:
| Title: | FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models. |
|---|---|
| Authors: | Weeden T; Dyne Therapeutics Inc, Waltham, MA, USA., Picariello T; Dyne Therapeutics Inc, Waltham, MA, USA., Quinn B; Dyne Therapeutics Inc, Waltham, MA, USA., Spring S; Dyne Therapeutics Inc, Waltham, MA, USA.; Pheon Therapeutics, Cambridge, MA, USA., Shen PY; Dyne Therapeutics Inc, Waltham, MA, USA., Qiu Q; Dyne Therapeutics Inc, Waltham, MA, USA., Vieira BF; Dyne Therapeutics Inc, Waltham, MA, USA., Schlaefke L; Dyne Therapeutics Inc, Waltham, MA, USA., Russo RJ; Dyne Therapeutics Inc, Waltham, MA, USA., Chang YA; Dyne Therapeutics Inc, Waltham, MA, USA., Cui J; Dyne Therapeutics Inc, Waltham, MA, USA., Yao M; Dyne Therapeutics Inc, Waltham, MA, USA., Wen A; Dyne Therapeutics Inc, Waltham, MA, USA.; Rona Therapeutics, Shanghai, China., Hsia N; Dyne Therapeutics Inc, Waltham, MA, USA., Evron T; Dyne Therapeutics Inc, Waltham, MA, USA., Ovington K; Dyne Therapeutics Inc, Waltham, MA, USA.; 4:59 NewCo, a 5AM Ventures Company, Boston, MA, USA., Tsai PN; Dyne Therapeutics Inc, Waltham, MA, USA.; Generation Bio, Cambridge, MA, USA., Yoder N; Dyne Therapeutics Inc, Waltham, MA, USA., Lan B; Dyne Therapeutics Inc, Waltham, MA, USA.; Summation Bio, Cambridge, MA, USA., Venkatesan R; Dyne Therapeutics Inc, Waltham, MA, USA., Hall J; Dyne Therapeutics Inc, Waltham, MA, USA., Desjardins CA; Dyne Therapeutics Inc, Waltham, MA, USA., Qatanani M; Dyne Therapeutics Inc, Waltham, MA, USA.; Scholar Rock, Cambridge, MA, USA., Hilderbrand S; Dyne Therapeutics Inc, Waltham, MA, USA., Najim J; Dyne Therapeutics Inc, Waltham, MA, USA., Tang Z; University of Rochester Medical Center, Rochester, NY, USA., Tanner MK; University of Rochester Medical Center, Rochester, NY, USA., Subramanian R; Dyne Therapeutics Inc, Waltham, MA, USA., Thornton CA; University of Rochester Medical Center, Rochester, NY, USA., Ibraghimov-Beskrovnaya O; Dyne Therapeutics Inc, Waltham, MA, USA., Zanotti S; Dyne Therapeutics Inc, Waltham, MA, USA. szanotti@dyne-tx.com. |
| Source: | Communications medicine [Commun Med (Lond)] 2025 Jan 18; Vol. 5 (1), pp. 22. Date of Electronic Publication: 2025 Jan 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
